Exoheal, founded in 2016, is an innovative player in the field of hand rehabilitation technology. The company's focus is on developing personalized robotic therapy systems, designed to assist patients in regaining hand mobility both at home and in clinical environments. Driven by the slogan, "Personalized therapy that helps patients rebuild hand movement at home and in clinics", Exoheal is addressing a critical need in the healthcare industry.
The solution offered by Exoheal is particularly noteworthy for its adaptability, adjusting to the unique requirements of each patient. By doing so, it aims to accelerate recovery processes and minimize reliance on costly, clinic-based rehabilitation equipment. The product has been collaboratively developed with healthcare professionals to ensure practicality and efficacy in real-world applications.
The company's growth trajectory is supported by a recent investment of $100.00K from the Constructor Start-Up Incubator Program as of November 2022. This injection of capital underscores investor confidence in Exoheal's potential to enhance access to quality rehabilitation beyond traditional settings.